Evolution of the development, regulation and use of biosimilars
Cancer diagnosis and core demands
• Diagnostics by sequencing and digital PCR. What can we expect? Liz Maria de Almeida, INCA
• Patient Avatars for predicting cancer treatment response, Daniele Ferreira,
Invitrocue
• Liquid biopsy for cancer treatment follow-up, Anamaria Camargo, Hospital Sirio
Libanes
Chair: Antonio Gomes Pinto Ferreira, Bio-Manguinhos
One Health and preparedness for the next pandemic
• Peter Daszak, President, EcoHealth
• A. Alonso Aguirre, Colorado State University*
Chair: Maurício Zuma, Bio-Manguinhos
▪ Poster Award Independent Committee
▪ Mauricio Zuma, Bio-Manguinhos
Event close-up remarks
Akira Homma, Bio-Manguinhos
